Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Invested Capital (2018 - 2025)

TransMedics has reported Return on Invested Capital over the past 8 years, most recently at 22.77% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 22.77% for Q4 2025, up 2260.0% from a year ago — trailing twelve months through Dec 2025 was 22.77% (up 2260.0% YoY), and the annual figure for FY2025 was 0.29%, up 9.0%.
  • Return on Invested Capital for Q4 2025 was 22.77% at TransMedics, up from 0.28% in the prior quarter.
  • Over the last five years, Return on Invested Capital for TMDX hit a ceiling of 22.77% in Q4 2025 and a floor of 0.77% in Q2 2022.
  • Median Return on Invested Capital over the past 5 years was 0.15% (2022), compared with a mean of 0.99%.
  • Biggest five-year swings in Return on Invested Capital: plummeted -48bps in 2022 and later soared 2260bps in 2025.
  • TransMedics' Return on Invested Capital stood at 0.4% in 2021, then soared by 58bps to 0.17% in 2022, then dropped by -30bps to 0.22% in 2023, then soared by 178bps to 0.17% in 2024, then surged by 13297bps to 22.77% in 2025.
  • The last three reported values for Return on Invested Capital were 22.77% (Q4 2025), 0.28% (Q3 2025), and 0.25% (Q2 2025) per Business Quant data.